Literature DB >> 23090117

Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells.

Lee-Hwa Tai1, Christiano Tanese de Souza, Simon Bélanger, Lundi Ly, Almohanad A Alkayyal, Jiqing Zhang, Julia L Rintoul, Abhirami A Ananth, Tiffany Lam, Caroline J Breitbach, Theresa J Falls, David H Kirn, John C Bell, Andrew P Makrigiannis, Rebecca A Auer.   

Abstract

Natural killer (NK) cell clearance of tumor cell emboli following surgery is thought to be vital in preventing postoperative metastases. Using a mouse model of surgical stress, we transferred surgically stressed NK cells into NK-deficient mice and observed enhanced lung metastases in tumor-bearing mice as compared with mice that received untreated NK cells. These results establish that NK cells play a crucial role in mediating tumor clearance following surgery. Surgery markedly reduced NK cell total numbers in the spleen and affected NK cell migration. Ex vivo and in vivo tumor cell killing by NK cells were significantly reduced in surgically stressed mice. Furthermore, secreted tissue signals and myeloid-derived suppressor cell populations were altered in surgically stressed mice. Significantly, perioperative administration of oncolytic parapoxvirus ovis (ORFV) and vaccinia virus can reverse NK cell suppression, which correlates with a reduction in the postoperative formation of metastases. In human studies, postoperative cancer surgery patients had reduced NK cell cytotoxicity, and we show for the first time that oncolytic vaccinia virus markedly increases NK cell activity in patients with cancer. These data provide direct in vivo evidence that surgical stress impairs global NK cell function. Perioperative therapies aimed at enhancing NK cell function will reduce metastatic recurrence and improve survival in surgical cancer patients.

Entities:  

Mesh:

Year:  2012        PMID: 23090117     DOI: 10.1158/0008-5472.CAN-12-1993

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  72 in total

1.  A mouse tumor model of surgical stress to explore the mechanisms of postoperative immunosuppression and evaluate novel perioperative immunotherapies.

Authors:  Lee-Hwa Tai; Christiano Tanese de Souza; Shalini Sahi; Jiqing Zhang; Almohanad A Alkayyal; Abhirami Anu Ananth; Rebecca A C Auer
Journal:  J Vis Exp       Date:  2014-03-12       Impact factor: 1.355

2.  Panorama from the oncolytic virotherapy summit.

Authors:  Jonathan G Pol; Monique Marguerie; Rozanne Arulanandam; John C Bell; Brian D Lichty
Journal:  Mol Ther       Date:  2013-10       Impact factor: 11.454

3.  Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer.

Authors:  Kathryn Ottolino-Perry; Sergio A Acuna; Fernando A Angarita; Clara Sellers; Siham Zerhouni; Nan Tang; J Andrea McCart
Journal:  Mol Oncol       Date:  2015-05-06       Impact factor: 6.603

4.  Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model.

Authors:  Ashkan Safavi; Amirhosein Kefayat; Elham Mahdevar; Fatemeh Ghahremani; Navid Nezafat; Mohammad Hossein Modarressi
Journal:  Hum Vaccin Immunother       Date:  2020-06-04       Impact factor: 3.452

Review 5.  Killers 2.0: NK cell therapies at the forefront of cancer control.

Authors:  Jonathan J Hodgins; Sarwat T Khan; Maria M Park; Rebecca C Auer; Michele Ardolino
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

6.  Cell-based immunotherapy in stage IIIA inflammatory breast cancer with declining innate immunity following successive chemotherapies: A case report.

Authors:  Ranganathan Chidambaram; Hiroshi Terunuma; Madasamy Balamurugan; Vidyasagar Devaprasad Dedeepiya; Premkumar Sumana; Rajappa Senthilkumar; Mathaiyan Rajmohan; Ramalingam Karthick; Senthilkumar Preethy; Samuel J K Abraham
Journal:  Mol Clin Oncol       Date:  2017-07-19

7.  Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity.

Authors:  Lee-Hwa Tai; Almohanad A Alkayyal; Amanda L Leslie; Shalini Sahi; Sean Bennett; Christiano Tanese de Souza; Katherine Baxter; Leonard Angka; Rebecca Xu; Michael A Kennedy; Rebecca C Auer
Journal:  Oncoimmunology       Date:  2018-03-01       Impact factor: 8.110

8.  Laparoscopic surgery minimizes the release of circulating tumor cells compared to open surgery for hepatocellular carcinoma.

Authors:  Wenda Li; Xue Zhou; ZeJian Huang; Hongwei Zhang; Lei Zhang; Changzhen Shang; Yajin Chen
Journal:  Surg Endosc       Date:  2014-12-25       Impact factor: 4.584

Review 9.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

10.  Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer.

Authors:  Yuto Baba; Eiji Kikuchi; Keisuke Shigeta; Koichiro Ogihara; Masashi Matsushima; Yui Nishimoto; Yasuaki Murata; Hirotaka Asakura; Masafumi Oyama; Ryuichi Mizuno; Mototsugu Oya
Journal:  Int J Clin Oncol       Date:  2021-08-06       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.